Direct answer: Do not divide a prescribed Zepbound weekly dose into smaller, more frequent injections on your own. Current prescribing information uses once-weekly dosing. The multi-dose vial and single-patient KwikPen contain four labeled weekly doses; they do not establish a twice-weekly split schedule.
What the current label supports
The April 2026 prescribing information describes a 2.5 mg once-weekly starting dose for four weeks, followed by 5 mg once weekly. If needed, increases are made in 2.5 mg steps only after at least four weeks on the current dose. It tells prescribers to consider response and tolerability and to consider a lower maintenance dose when a maintenance dose is not tolerated.
The label does not provide a twice-weekly Zepbound regimen, half-dose conversion chart, or instructions for withdrawing a fraction of a labeled dose.
Why multi-dose does not mean split dosing
| Presentation | Label-supported use |
|---|---|
| Single-dose pen or vial | One labeled dose once weekly |
| Multi-dose vial | Four 0.6 mL labeled doses, used once weekly |
| Single-patient-use KwikPen | Four labeled doses, used once weekly |
Concentrations differ by strength and presentation. A universal insulin-syringe “units” chart can therefore give the wrong answer for the product in hand.
What to discuss instead
- Confirm the exact presentation, strength, and Instructions for Use.
- Record the symptom, severity, timing after injection, hydration, and effect on eating.
- Ask whether to remain at the current dose longer, use an appropriate manufactured strength, pause escalation, or choose another treatment.
- Check insurance, savings eligibility, and the current pharmacy price rather than changing a dose to stretch supply.
Do not transfer medication out of a pen, estimate a partial pen dose, reuse a single-dose vial, or apply compounded-tirzepatide conversion instructions to branded Zepbound.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Missed-dose instructions are different
The label says a missed dose may be taken within four days. If more than four days have passed, skip it and take the next dose on the regular day. A weekly administration day may be changed when at least three days separate two doses. These are not instructions for routine twice-weekly dosing.
Frequently asked questions
Can a Zepbound pen dose be split?
No FDA-reviewed instruction supports extracting or partially delivering a Zepbound single-dose pen.
Does a multi-dose vial permit twice-weekly dosing?
No. It contains four labeled doses, while the prescribing information still directs one dose once weekly.
Is there an official Zepbound half-dose chart?
No FDA-reviewed chart instructs patients to convert a weekly Zepbound dose into two half-doses.
What if the next strength causes side effects?
Contact the prescriber before another injection or schedule change. Seek prompt care for severe or rapidly worsening symptoms.
Primary sources
- Eli Lilly, Zepbound prescribing information (revised April 2026)
- FDA Drugs@FDA: Zepbound application record
Evidence review completed July 31, 2026.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →